©2018 by Taby diagnostics

Cancer Diagnosis

Early Detection of Several Types of Cancer

 
LIVER CANCER...

700.000

NEW CASES EVERY YEAR

50%

80%

CURED IF EARLY DIAGNOSED

DIE

OUR PRODUCTS

yliver is a blood test that detects alpha-fetoprotein autoantibodies. Taby diagnostics provides this test to hospitals and associated laboratories to early diagnose liver cancer with a sensitivity of 100% and a specificity of 94% 

 

OUR TECHNOLOGY

Taby diagnostics tecnhology increases the immunogenicity of tumor-associated antigens

1
2
3

Applying Taby technology to modify the tumor-associated antigen (TAA)

Sensitizing plate with modified TAA

Immunoassy with our IVD kit using serum 

 
IMG_0155.jpg

Co-founder & CEO

XAVIER GALLEGO

PhD in Biology with an entrepreneurial mindset and wide experience on project management, innovation, and technology transfer.

linkedin.png
IMG_0161.jpg

Co-founder & CMO

JUAN Fco DELGADO

Medical doctor specialist in immunology with 10 years of experience in clinical practice. Expert on tumor-associated antigens autoantibodies.

linkedin.png

ABOUT US

Taby diagnostics is a spin-off of Parc Taulí University Hospital. Its mission is to provide the society with a tool to early diagnose several types of cancer. 

TABY DIAGNOSTICS
 

SPONSORS

 

CONTACT US

Parc Taulí, 1
Sabadell, 08208
Spain